{
  "main_header": {
    "sid": 999951,
    "name": "Symbiox Investme",
    "stock_name": "Symbiox Investme",
    "full_name": "Symbiox Investment & Trading Co Ltd",
    "name_url": "stocks-analysis/symbiox-investme",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "3.20",
    "chg": 0.04,
    "chgp": "1.27%",
    "dir": 1,
    "prev_price": "3.16",
    "mcapval": "10.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539278,
    "symbol": "",
    "ind_name": "Finance/NBFC",
    "ind_code": 5,
    "isin": "INE653R01012",
    "curr_date": "Apr 11, 12:47 PM",
    "curr_time": "00:14 AM",
    "bse_nse_vol": "9.2 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/symbiox-investme-999951-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Symbiox Investment & Trading Co Ltd Experiences Strong Buying Amid Mixed Performance Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/symbiox-investment-trading-co-ltd-gains-1-54-over-week-despite-0-90-decline-today-1693557",
        "imagepath": "",
        "date": "2025-04-03 09:35:44",
        "description": "Symbiox Investment & Trading Co Ltd is currently witnessing strong buying activity, with all trades reflecting buyer interest. Despite a slight decline of 0.90% today, the stock has shown resilience over the past week, gaining 1.54%, while the Sensex has decreased by 1.85% during the same period. However, the stock's performance over the past month has been challenging, with a decline of 12.00%, contrasting sharply with the Sensex's increase of 4.22%.\n\nIn terms of longer-term performance, Symbiox has faced significant headwinds, with a 42.91% drop over the last three months, while the Sensex has only decreased by 3.85%. Notably, the stock has performed well over the past five years, boasting an impressive increase of 1636.84%, compared to the Sensex's 176.07%.\n\nToday's trading session opened with a gap up, but the stock remains below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. The combi..."
      },
      {
        "title": "Symbiox Investment & Trading Co Ltd Sees Increased Buying Activity Amid Market Sentiment Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/symbiox-investment-trading-co-ltd-rises-1-83-today-amid-mixed-performance-trends-1673392",
        "imagepath": "",
        "date": "2025-04-02 09:45:14",
        "description": "Symbiox Investment & Trading Co Ltd is witnessing significant buying activity today, with a notable increase of 1.83%, outperforming the Sensex, which rose by 0.47%. This marks a positive shift in sentiment for the microcap finance/NBFC company, especially given its recent performance trends. Over the past week, Symbiox has seen a slight decline of 0.89%, while the Sensex fell by 1.17%. However, the stock's performance over the past month shows a more considerable drop of 14.62%, contrasting sharply with the Sensex's gain of 4.35%.\n\nDespite a challenging three-month period, where Symbiox's stock decreased by 39.67% compared to the Sensex's decline of 4.45%, the one-year performance reveals a more favorable outlook, with a gain of 19.78% against the Sensex's 3.35%. Year-to-date, the stock is down 38.56%, while the Sensex has only dipped by 2.25%. \n\nToday's trading opened with a gap up, and the intraday high ..."
      },
      {
        "title": "Symbiox Investment & Trading Co. Adjusts Valuation Amidst Competitive Financial Landscape",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/symbiox-investment-trading-co-changes-valuation-grade-from-fair-to-attractive-1670156",
        "imagepath": "",
        "date": "2025-04-02 08:02:31",
        "description": "Symbiox Investment & Trading Co., a microcap player in the finance/NBFC sector, has recently undergone a valuation adjustment, reflecting its current financial standing. The company's price-to-earnings ratio stands at 10.23, while its price-to-book value is notably low at 0.32. Other metrics, such as EV to EBIT and EV to EBITDA, are both reported at -0.88, indicating a challenging operational environment. The return on equity (ROE) is at 1.47%, which suggests modest profitability relative to shareholder equity.\n\nIn comparison to its peers, Symbiox's valuation metrics appear more favorable, particularly when contrasted with companies like Colab Platforms and Oswal Green Tech, which exhibit significantly higher price-to-earnings ratios and EV multiples. This positions Symbiox as a relatively attractive option within its industry, despite its recent performance challenges. Over the past year, the stock has sho..."
      },
      {
        "title": "Symbiox Investment Faces Intense Selling Pressure Amid Consecutive Losses and Market Divergence",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/symbiox-investment-trading-co-ltd-faces-heavy-selling-pressure-with-42-80-year-to-date-loss-1641789",
        "imagepath": "",
        "date": "2025-03-28 11:30:12",
        "description": "Symbiox Investment & Trading Co Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses, with a decline of 4.62% in just one day, marking a total drop of 7.74% over the last two days. This trend is particularly concerning given the stock's performance relative to the Sensex, which has only decreased by 0.14% today.\n\nOver the past week, Symbiox has seen a decline of 9.09%, while the Sensex has gained 0.77%. The one-month performance reveals a stark contrast, with Symbiox down 20.51% compared to the Sensex's increase of 5.87%. The year-to-date performance is equally troubling, showing a decline of 42.80% against the Sensex's slight decrease of 0.82%.\n\nThe stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent downward trend. Contributing factors to this selling press..."
      },
      {
        "title": "Symbiox Investment Faces Intense Selling Pressure Amid Consecutive Losses and Market Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/symbiox-investment-trading-co-ltd-faces-significant-selling-pressure-with-39-30-year-to-date-loss-1624483",
        "imagepath": "",
        "date": "2025-03-27 11:05:11",
        "description": "Symbiox Investment & Trading Co Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has recorded consecutive days of losses, with a notable decline of 2.08% in its one-day performance, contrasting sharply with the Sensex, which gained 0.50% during the same period. Over the past week, Symbiox has also underperformed, with a total loss of 2.08%, while the Sensex rose by 1.73%.\n\nIn the longer term, the stock's performance has been concerning. Over the past month, it has dropped 17.34%, compared to a 4.10% increase in the Sensex. The three-month performance shows a decline of 35.49%, while the Sensex fell only 1.30%. Year-to-date, Symbiox has plummeted 39.30%, against a slight decline of 0.60% in the Sensex. \n\nDespite a strong five-year performance of 1631.58%, the recent trends indicate a significant downturn. The stock is currently trading above its fiv..."
      },
      {
        "title": "Symbiox Investment & Trading Co Ltd Faces Intense Selling Pressure Amid Significant Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/symbiox-investment-trading-co-ltd-faces-significant-selling-pressure-with-40-04-year-to-date-loss-1575233",
        "imagepath": "",
        "date": "2025-03-24 15:05:11",
        "description": "Symbiox Investment & Trading Co Ltd is currently facing significant selling pressure, with the stock showing only sellers today. This trend marks a continuation of consecutive days of losses, as the stock has declined by 4.69% in just one day. Over the past week, it has experienced a total drop of 9.72%, and its performance over the last month reveals a staggering decline of 20.73%. \n\nIn comparison to the Sensex, which has gained 1.28% today, Symbiox's performance starkly contrasts with the broader market. The stock has underperformed the Sensex significantly over various time frames, including a 37.62% decline over the past three months and a year-to-date drop of 40.04%. \n\nSeveral factors may be contributing to this selling pressure, including the stock's consistent underperformance relative to key moving averages, as it is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving aver..."
      },
      {
        "title": "Symbiox Investment & Trading Co Ltd Sees Strong Buying Activity Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/symbiox-investment-trading-co-ltd-surges-5-36-today-despite-recent-weekly-decline-of-4-84-1554580",
        "imagepath": "",
        "date": "2025-03-21 15:05:16",
        "description": "Symbiox Investment & Trading Co Ltd is currently witnessing significant buying activity, with the stock rising by 5.36% today, contrasting sharply with the Sensex's modest gain of 0.69%. This uptick comes after two consecutive days of decline, indicating a potential trend reversal. However, over the past week, the stock has underperformed, declining by 4.84% compared to the Sensex's increase of 4.13%.\n\nIn terms of longer-term performance, Symbiox has faced challenges, with a 15.71% drop over the past month and a notable 34.69% decline year-to-date. Despite these setbacks, the stock has shown resilience over the past year, appreciating by 26.88%, significantly outperforming the Sensex's 5.83% gain.\n\nToday's trading session opened with a gap up, and the intraday high reflects the strong buying momentum. However, the stock remains below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggestin..."
      },
      {
        "title": "Symbiox Investment Faces Intense Selling Pressure Amid Significant Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/symbiox-investment-trading-co-ltd-faces-significant-selling-pressure-with-4-86-decline-today-1502604",
        "imagepath": "",
        "date": "2025-03-20 11:55:10",
        "description": "Symbiox Investment & Trading Co Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The stock has experienced consecutive losses, falling 4.86% in just one day, and has declined 8.01% over the last two days. This trend is particularly concerning as the stock has underperformed the broader market, with the Sensex gaining 0.64% on the same day.\n\nOver the past week, Symbiox has seen a notable decline of 10.48%, while the Sensex rose by 2.85%. The one-month performance reveals a staggering drop of 21.09% for Symbiox, contrasting sharply with the Sensex's modest increase of 0.26%. Year-to-date, the stock has plummeted 38.56%, while the Sensex has only dipped 2.83%.\n\nThe stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent downward trend. Contributing factors to this selling pressure may include broad..."
      },
      {
        "title": "Symbiox Investment & Trading Co. Adjusts Valuation Amid Strong Yearly Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/symbiox-investment-trading-cos-valuation-grade-changes-from-fair-to-expensive-1516381",
        "imagepath": "",
        "date": "2025-03-11 08:00:36",
        "description": "Symbiox Investment & Trading Co., a microcap player in the finance/NBFC sector, has recently undergone a valuation adjustment. The company's current price stands at 3.94, reflecting a slight increase from the previous close of 3.73. Over the past year, Symbiox has shown a return of 30.9%, significantly outperforming the Sensex, which remained nearly flat during the same period.\n\nKey financial metrics for Symbiox include a PE ratio of 12.33 and an EV to EBITDA ratio of 1.22, indicating its market positioning relative to its peers. The company's return on capital employed (ROCE) and return on equity (ROE) are reported at 1.35% and 1.47%, respectively, which provide insight into its operational efficiency.\n\nIn comparison to its peers, Symbiox's valuation metrics suggest a competitive stance, particularly when contrasted with companies like Centrum Capital and Vardhman Holdings. While some peers exhibit higher ..."
      }
    ],
    "total": 32,
    "sid": "999951",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/symbiox-investment-trading-co-999951"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Mar-2025",
      "details": "Intimation of Closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 11Th February 2025",
      "datetime": "11-Feb-2025",
      "details": "pfa",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Notice Of 5Th /2024-25 Board Meeting To Be Held On 11Th February 2025",
      "datetime": "31-Jan-2025",
      "details": "Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve Kindly take note of the same on your records.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Symbiox Investment & Trading Co Ltd Experiences Strong Buying Amid Mixed Performance Trends

2025-04-03 09:35:44

Symbiox Investment & Trading Co Ltd is currently witnessing strong buying activity, with all trades reflecting buyer interest. Despite a slight decline of 0.90% today, the stock has shown resilience over the past week, gaining 1.54%, while the Sensex has decreased by 1.85% during the same period. However, the stock's performance over the past month has been challenging, with a decline of 12.00%, contrasting sharply with the Sensex's increase of 4.22%. In terms of longer-term performance, Symbiox has faced significant headwinds, with a 42.91% drop over the last three months, while the Sensex has only decreased by 3.85%. Notably, the stock has performed well over the past five years, boasting an impressive increase of 1636.84%, compared to the Sensex's 176.07%. Today's trading session opened with a gap up, but the stock remains below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. The combi...

Read More

Symbiox Investment & Trading Co Ltd Sees Increased Buying Activity Amid Market Sentiment Shift

2025-04-02 09:45:14

Symbiox Investment & Trading Co Ltd is witnessing significant buying activity today, with a notable increase of 1.83%, outperforming the Sensex, which rose by 0.47%. This marks a positive shift in sentiment for the microcap finance/NBFC company, especially given its recent performance trends. Over the past week, Symbiox has seen a slight decline of 0.89%, while the Sensex fell by 1.17%. However, the stock's performance over the past month shows a more considerable drop of 14.62%, contrasting sharply with the Sensex's gain of 4.35%. Despite a challenging three-month period, where Symbiox's stock decreased by 39.67% compared to the Sensex's decline of 4.45%, the one-year performance reveals a more favorable outlook, with a gain of 19.78% against the Sensex's 3.35%. Year-to-date, the stock is down 38.56%, while the Sensex has only dipped by 2.25%. Today's trading opened with a gap up, and the intraday high ...

Read More

Symbiox Investment & Trading Co. Adjusts Valuation Amidst Competitive Financial Landscape

2025-04-02 08:02:31

Symbiox Investment & Trading Co., a microcap player in the finance/NBFC sector, has recently undergone a valuation adjustment, reflecting its current financial standing. The company's price-to-earnings ratio stands at 10.23, while its price-to-book value is notably low at 0.32. Other metrics, such as EV to EBIT and EV to EBITDA, are both reported at -0.88, indicating a challenging operational environment. The return on equity (ROE) is at 1.47%, which suggests modest profitability relative to shareholder equity. In comparison to its peers, Symbiox's valuation metrics appear more favorable, particularly when contrasted with companies like Colab Platforms and Oswal Green Tech, which exhibit significantly higher price-to-earnings ratios and EV multiples. This positions Symbiox as a relatively attractive option within its industry, despite its recent performance challenges. Over the past year, the stock has sho...

Read More

Symbiox Investment Faces Intense Selling Pressure Amid Consecutive Losses and Market Divergence

2025-03-28 11:30:12

Symbiox Investment & Trading Co Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses, with a decline of 4.62% in just one day, marking a total drop of 7.74% over the last two days. This trend is particularly concerning given the stock's performance relative to the Sensex, which has only decreased by 0.14% today. Over the past week, Symbiox has seen a decline of 9.09%, while the Sensex has gained 0.77%. The one-month performance reveals a stark contrast, with Symbiox down 20.51% compared to the Sensex's increase of 5.87%. The year-to-date performance is equally troubling, showing a decline of 42.80% against the Sensex's slight decrease of 0.82%. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent downward trend. Contributing factors to this selling press...

Read More

Symbiox Investment Faces Intense Selling Pressure Amid Consecutive Losses and Market Underperformance

2025-03-27 11:05:11

Symbiox Investment & Trading Co Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has recorded consecutive days of losses, with a notable decline of 2.08% in its one-day performance, contrasting sharply with the Sensex, which gained 0.50% during the same period. Over the past week, Symbiox has also underperformed, with a total loss of 2.08%, while the Sensex rose by 1.73%. In the longer term, the stock's performance has been concerning. Over the past month, it has dropped 17.34%, compared to a 4.10% increase in the Sensex. The three-month performance shows a decline of 35.49%, while the Sensex fell only 1.30%. Year-to-date, Symbiox has plummeted 39.30%, against a slight decline of 0.60% in the Sensex. Despite a strong five-year performance of 1631.58%, the recent trends indicate a significant downturn. The stock is currently trading above its fiv...

Read More

Symbiox Investment & Trading Co Ltd Faces Intense Selling Pressure Amid Significant Losses

2025-03-24 15:05:11

Symbiox Investment & Trading Co Ltd is currently facing significant selling pressure, with the stock showing only sellers today. This trend marks a continuation of consecutive days of losses, as the stock has declined by 4.69% in just one day. Over the past week, it has experienced a total drop of 9.72%, and its performance over the last month reveals a staggering decline of 20.73%. In comparison to the Sensex, which has gained 1.28% today, Symbiox's performance starkly contrasts with the broader market. The stock has underperformed the Sensex significantly over various time frames, including a 37.62% decline over the past three months and a year-to-date drop of 40.04%. Several factors may be contributing to this selling pressure, including the stock's consistent underperformance relative to key moving averages, as it is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving aver...

Read More

Symbiox Investment & Trading Co Ltd Sees Strong Buying Activity Amid Market Volatility

2025-03-21 15:05:16

Symbiox Investment & Trading Co Ltd is currently witnessing significant buying activity, with the stock rising by 5.36% today, contrasting sharply with the Sensex's modest gain of 0.69%. This uptick comes after two consecutive days of decline, indicating a potential trend reversal. However, over the past week, the stock has underperformed, declining by 4.84% compared to the Sensex's increase of 4.13%. In terms of longer-term performance, Symbiox has faced challenges, with a 15.71% drop over the past month and a notable 34.69% decline year-to-date. Despite these setbacks, the stock has shown resilience over the past year, appreciating by 26.88%, significantly outperforming the Sensex's 5.83% gain. Today's trading session opened with a gap up, and the intraday high reflects the strong buying momentum. However, the stock remains below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggestin...

Read More

Symbiox Investment Faces Intense Selling Pressure Amid Significant Price Declines

2025-03-20 11:55:10

Symbiox Investment & Trading Co Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The stock has experienced consecutive losses, falling 4.86% in just one day, and has declined 8.01% over the last two days. This trend is particularly concerning as the stock has underperformed the broader market, with the Sensex gaining 0.64% on the same day. Over the past week, Symbiox has seen a notable decline of 10.48%, while the Sensex rose by 2.85%. The one-month performance reveals a staggering drop of 21.09% for Symbiox, contrasting sharply with the Sensex's modest increase of 0.26%. Year-to-date, the stock has plummeted 38.56%, while the Sensex has only dipped 2.83%. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent downward trend. Contributing factors to this selling pressure may include broad...

Read More

Symbiox Investment & Trading Co. Adjusts Valuation Amid Strong Yearly Performance

2025-03-11 08:00:36

Symbiox Investment & Trading Co., a microcap player in the finance/NBFC sector, has recently undergone a valuation adjustment. The company's current price stands at 3.94, reflecting a slight increase from the previous close of 3.73. Over the past year, Symbiox has shown a return of 30.9%, significantly outperforming the Sensex, which remained nearly flat during the same period. Key financial metrics for Symbiox include a PE ratio of 12.33 and an EV to EBITDA ratio of 1.22, indicating its market positioning relative to its peers. The company's return on capital employed (ROCE) and return on equity (ROE) are reported at 1.35% and 1.47%, respectively, which provide insight into its operational efficiency. In comparison to its peers, Symbiox's valuation metrics suggest a competitive stance, particularly when contrasted with companies like Centrum Capital and Vardhman Holdings. While some peers exhibit higher ...

Read More

View All News